Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy

Napolitano M, D'Amico F, Ragaini E, Peyrin-Biroulet L, Danese S

Drug Design, Development and Therapy 2022, 16:1897-1913

Published Date: 17 June 2022